---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-23-000049"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T09:13:57.748451+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q2 net revenue $255M (-4% YoY), net income $24M; cuts full-year outlook

## Summary
- Q2 net revenues $255M, down 4% YoY; net income $24M ($0.08 diluted EPS) vs $30M ($0.11) in Q2 2022.
- Adjusted EBITDA $128M, down 6% YoY; Adjusted EPS $0.21 vs $0.27 in prior year.
- Full-year 2023 guidance revised: net revenue $1.035B-$1.055B, Adjusted EBITDA $520M-$535M.
- Decline driven by expected Nordion Cobalt-60 harvest schedule timing.
- Total debt $2.3B, net leverage ratio 4.2x as of June 30, 2023.

## SEC filing metadata
- accession: 0001822479-23-000049
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000049/0001822479-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000049/shc-20230803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-23-000049
- JSON: https://secwatch.observer/filing/0001822479-23-000049.json
- Plain text: https://secwatch.observer/filing/0001822479-23-000049.txt

## Key facts
- Earnings Releases
  Sotera Health Co reported the quarter ended June 30, 2023 results: revenue $255 million, net income $24 million or $0.08 per diluted share, EPS $0.08 per diluted share. Guidance reaffirmed.
  - Period: the quarter ended June 30, 2023
  - Revenue: $255 million
  - Net income: $24 million or $0.08 per diluted share
  - EPS: $0.08 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sotera Health Reports Second-Quarter and First-Half 2023 Results • Q2 2023 net revenues of $255 million decreased 4%, compared to Q2 2022, primarily driven by expected Nordion Cobalt-60 harvest schedule timing • Q2 2023 net income of $24 million or $0.08 per diluted share, compared
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000049/0001822479-23-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.